Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now owns 96,343 shares of the company’s stock, […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now directly owns 96,343 shares of […]
Equities Research Analysts’ new coverage for Thursday, April 4th: StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD). They […]
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) had its price target decreased by investment analysts at Craig Hallum from $2.00 to $1.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical research company’s stock. Craig Hallum’s price objective suggests a potential […]